Aravive Inc (ARAV)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

RIVER OAKS TOWER HOUSTON, TX 77098

Versartis, Inc. operates as a biotechnology company. The company develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Versartis serves patients throughout the United States.

Data as of 2020-11-22
Market Cap88.319 Million Shares Outstanding16.087 Million Avg 30-day Volume117.219 Thousand
P/E Ratio-2.7 Dividend Yield EPS-2.04
Price/Sales Price cash flow ratio Price free cash flow ratio-4.1
Book Value3.07 Price to Tangible Book1.79 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.212643
BETA3.24964 52-week High/Low14.94 / 3.34 Stddev0.296969
View SEC Filings from ARAV instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 51 53 -3.77% 14 (0.92%) 15 (0.97%) -6.67%
13F shares: 6.546 Million 8.303 Million -21.16% 2.49 Million 3.344 Million -25.52%
% Ownership 40.7144 51.8323 -21.45% 15.4902 20.8764 -25.8%
New Positions: 9 22 -59.09% 4 4 0.0%
Increased Positions 15 17 -11.76% 7 4 75.0%
Closed Positions 11 5 120.0% 5 2 150.0%
Reduced Positions 19 9 111.11% 2 5 -60.0%
Total Calls 19.301 Thousand 22 Thousand -12.27% 19.3 Thousand
Total Puts 13.201 Thousand 2 659950.0%
PUT/CALL Ratio 0.68 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARAV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARAV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RANGWALA RESHMA CHIEF MEDICAL OFFICER

  • Officer
0 2020-09-28 2

ROGERS MICHAEL W

  • Director
0 2020-09-15 2

GIACCIA AMATO

  • Director
0 2020-09-14 1

TABIBIAZAR RAYMOND

  • Director
0 2020-09-14 1

ZHANG ERIC

  • Director
0 2020-09-14 1

ESHELMAN FREDRIC N

ESHELMAN VENTURES, LLC

  • Director
  • SEE REMARKS
0 2020-09-14 3

SHEPARD JAY

  • FORMER DIRECTOR
61,201 2020-04-08 3

AKKARAJU SRINIVAS

  • FORMER DIRECTOR
0 2020-04-08 2

HOFFMAN ROBERT

  • FORMER DIRECTOR
0 2020-04-08 1

MCINTYRE GAIL FRANCES CEO AND PRESIDENT

  • Officer
  • Director
0 2020-04-08 2

HEMRAJANI REKHA

  • SEE REMARKS
14,250 2020-04-08 3

SHAH VINAY CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-22 1

MALIK SHAHZAD

  • Director
0 2019-09-12 0

HAAS KEVIN VP, FINANCE AND PAO

  • Officer
0 2019-02-28 0

GIACCIA AMATO

GIACCIA AMATO

  • Director
  • 10% Owner
0 2019-01-03 1

SHEPARD JAY PRESIDENT AND CEO

SHEPARD JAY PRESIDENT AND CEO

  • Officer
  • Director
84,113 2018-12-21 3

WESTBERG PAUL SVP AND CHIEF BUSINESS OFFICER

  • Officer
225,124 2018-06-15 0

STOUT JAY S SVP, TECHNICAL OPERATIONS

  • Officer
185,646 2018-04-24 0

WOODY TRACY M CHIEF COMMERCIAL OFFICER

  • Officer
215,755 2018-03-23 0

WARD SHANE SVP AND GENERAL COUNSEL

  • Officer
201,556 2018-02-08 0

GREER R SCOTT

  • Director
44,380 2017-12-20 0

SUN ANTHONY Y

  • Director
23,880 2017-12-20 0

JENNINGS EDMON R

  • Director
22,380 2017-12-20 0

VARIAN JOHN

  • Director
22,280 2017-12-20 0

DOBMEIER ERIC

  • Director
18,160 2017-12-20 0

GUT ROBERT CHIEF MEDICAL OFFICER

  • Officer
227,300 2017-12-20 0

BRUMM JOSHUA T COO AND CFO

  • Officer
201,269 2017-10-19 0

HISLOP COLIN CHIEF MEDICAL OFFICER

  • Officer
23,833 2017-10-19 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
No longer subject to file 2017-09-21 0

CLELAND JEFFREY L PRESIDENT AND CEO

  • Officer
  • Director
121,548 2015-04-14 0

AISLING CAPITAL III LP

AISLING CAPITAL PARTNERS III LLC

AISLING CAPITAL PARTNERS III LP

ELMS STEVE

PURCELL DENNIS J

SCHIFF ANDREW N

  • 10% Owner
No longer subject to file 2015-01-27 0

ADVENT LIFE SCIENCES LLP

ADVENT LIFE SCIENCES FUND I LP

  • AFFILIATE OF DIRECTORAFFILIATE OF DIRECTOR
2,271,558 2015-01-22 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
No longer subject to file 2014-12-18 0

INDEX VENTURES IV (JERSEY) LP

INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) LP

YUCCA (JERSEY) SLP

  • 10% Owner
19,161 2014-11-24 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
3,359,374 2014-09-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments